资讯
Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in ...
Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...
Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...
Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...
A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...
A team of scientists has uncovered the mechanism of cellular uptake for large and polar drugs and devised a novel strategy to ...
Stimulating a receptor in adipocytes enhanced energy expenditure and caused sustained weight loss in mice, offering targets ...
Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in ...
One exciting area of research involves finding drugs that mimic the effects of caloric restriction. Some of the most ...
Discover the effectiveness and safety of Mounjaro, the new weight loss drug launched in India. Learn from expert Dr. Pal ...
Schizophrenia drug Cobenfy, a key component in Bristol Myers Squibb’s plan to navigate a transition period of major loss of ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果